What 86.6% Sensitivity Actually Buys
What 86.6% Sensitivity Actually Buys
Ada re-derives this chapter’s own numbers step by step, at full precision
ADA · CALCULATION AUDIT
What 86.6% Sensitivity Actually Buys
In a trial of 1,000 infants over 180 days, a self-powered smart diaper catches 71 of 82 real UTIs — a sensitivity of 86.6% — while raising only 32 false alarms across 180,000 monitoring-days, a specificity of 99.98% that helps prevent 7 kidney infections and turn a $30,000 device into a positive return. This is safety-critical, so the audit rebuilds the confusion matrix and asks what that modest-sounding 86.6% sensitivity actually buys — and whether it, or the specificity, is what makes the device adoptable.
Companion to the chapter Baby Monitoring — every number here comes from that chapter.
See the relationship before changing it
The figure reads from left to right. The blue card is true positives. The middle card applies the page rule. The green card is sensitivity. Walk the arrows once: set the input, apply the rule, then read the result with its unit.
Derive the baseline in four named moves
- 1
Name the input. The chapter baseline is 71 of 82 UTIs.
- 2
Name the relationship. sensitivity = true positives / 82 x 100
- 3
Substitute with units. 71 / 82 x 100 = 86.59%
- 4
Read the result. Keep the unit beside the value. Use it only inside the technical boundary on this page.
Predict, then change true positives
Try Predict the direction of sensitivity = true positives / 82 x 100. Test another true positives, then compare sensitivity.
Observe More true detections raise sensitivity; specificity is a separate safety gate. Reset true positives to 71 and compare sensitivity.
Explain More true detections raise sensitivity; specificity is a separate safety gate.
Check yourself
What should you do before trusting a moved-control result?
What does this small model leave out?
Ada: This is safety-critical, so every digit matters. The smart-diaper trial reports 86.6% sensitivity, 99.98% specificity, and a positive return. Let me rebuild the confusion matrix and the cost case from the raw counts – 82 real UTIs, 71 true positives, 32 false positives, 11 false negatives, over 180,000 monitoring-days.
- Sensitivity:
71 / (71 + 11) = 71 / 82 = 0.865854, which rounds to 86.6%. - Non-UTI days:
180,000 - 82 = 179,918; true negatives:179,918 - 32 = 179,886. - Specificity:
179,886 / 179,918 = 0.999822, which rounds to 99.98% – one false alarm per179,918 / 32 = 5,622clean days. - Prevented kidney infections:
82 x 0.125 - 82 x 0.04 = 10.25 - 3.28 = 6.97, which rounds to 7 cases. - Cost case:
7 x 7,000 = 49,000in avoided hospitalisation against a30,000device cost – a net49,000 - 30,000 = 19,000.
Every figure reconciles. The design meaning is that the modest-sounding 86.6% sensitivity is not what makes this device adoptable – the 99.98% specificity is, because at a base rate of 82 events in 180,000 days even a small false-positive rate would flood caregivers, and it is that near-zero false-alarm burden, not the detection rate, that keeps the $19,000 net benefit from being erased by lost parental trust.
This fixed-rate audit omits changing infant state, correlated sensor errors, alarm suppression, caregiver response, device placement, and clinical validation.
Work the audit first, then check the displayed derivation.
Every number above is taken from the chapter’s own material and re-derived step by step.